PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER

NIH RePORTER · NIH · N02 · $107,221 · view on reporter.nih.gov ↗

Abstract

The contractor will conduct a pre-surgical pilot study to evaluate the effect of daily exemestane on proliferation of endometrial tissue in post-menopausal women diagnosed with complex atypical hyperplasia/endometrial intraepithelial neoplasia or Grade 1 endometrial cancer.

Key facts

NIH application ID
10222480
Project number
261201200033I-P00005-26100011-1
Recipient
UNIVERSITY OF WISCONSIN-MADISON
Principal Investigator
HOWARD BAILEY
Activity code
N02
Funding institute
NIH
Fiscal year
2020
Award amount
$107,221
Award type
—
Project period
2017-09-15 → 2021-12-31